PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14559856-0	2003	FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway.	Tacrolimus	0-5	zinc fingers and homeoboxes 2	Homo sapiens	60-63	
14559856-4	2003	Inhibitors of Ras (lovastatin), Raf (GW5074), or MAP kinase (PD98059 and U0126) blocked FK506 activity, as did inhibitors of phospholipase C (U73122) and phosphatidylinositol 3" kinase (LY294002).	Tacrolimus	88-93	zinc fingers and homeoboxes 2	Homo sapiens	32-35	
14559856-6	2003	These data suggest that FK506 potentiates neurite outgrowth through the Ras/Raf/MAP kinase signaling pathway downstream of phospholipase C and phosphatidylinositol 3" kinase.	Tacrolimus	24-29	zinc fingers and homeoboxes 2	Homo sapiens	76-79	
8774885-4	1996	Oligomerization of recombinant FKBP-Raf in situ, induced by the addition of the dimeric FK506 derivative FK1012A, activated Raf kinase activity at least half as well as epidermal growth factor (EGF).	Tacrolimus	88-93	zinc fingers and homeoboxes 2	Homo sapiens	36-39	
8774885-4	1996	Oligomerization of recombinant FKBP-Raf in situ, induced by the addition of the dimeric FK506 derivative FK1012A, activated Raf kinase activity at least half as well as epidermal growth factor (EGF).	Tacrolimus	88-93	zinc fingers and homeoboxes 2	Homo sapiens	124-127